(Ondansetron) Side Effects, Dosage, Uses, Interaction

Опубликовал в личный блог
Send your Zofran Birth Defect claim to a Lawyer who will review your claim at NO COST or obligation. A mother from Massachusetts and a mother from Minnesota have both filed lawsuits against GSK in mid-February, raising nearly identical allegations that due to Zofran use during pregnancy, their children were born with severe birth defects. One complaint filed in the U.S. District Court for the Eastern District of Philadelphia on February 12 by Cheri Flynn indicates that her two children, born in 2004 and 2006, suffered congenital heart defects after exposure to Zofran during her pregnancy.

Another complaint filed by Tomesha LeClair in the U.S. District Court for the District of Massachusetts on February 16, indicates that her daughter suffered heart defects and several other congenital malformations due to the use of Zofran during her first trimester of pregnancy. Furthermore, the lawsuit states that these birth defects impair her development and enjoyment of a normal life at home and at school due to substantial developmental delays. Both lawsuits indicate that GSK has known the potential link between Zofran and birth defects for quite some time. In 1992, GSK started receiving mounting evidence of reports of birth defects associated with Zofran.

The complaints also say that GSK performed studies in the mid-1980s, which showed that Zofran crossed the placenta in rats and rabbits during pregnancy. The lawsuit also claims that despite their studies showing toxicity, premature births, intrauterine fetal deaths and incomplete bone growth, the company declared the tests showed no harm to fetuses. Zofran is on the World Health Organization's list of most essential medicines — but not when prescribed off-label.

By 2000, GSK had 32 reports of women who used the drug and later gave birth to women with congenital heart disease, dysmorphism, stillbirth, kidney defects, bone and skeletal problems and other birth defects. N.Y. Attorney General Eric T. Schneiderman announced that his office sent letters to four major retailers, GNC, Target, Walmart, and Walgreens, for allegedly selling store brand herbal supplement products in New York that either could not be verified to contain the labeled substance, or which were found to contain ingredients not listed on the labels.

Attorney General Schneiderman requested the companies provide detailed information relating to the production, processing and testing of herbal supplements sold at their stores, as well as set forth a thorough explanation of quality control measures in place. The only FDA-approved uses of Zofran are the treatment of nausea and vomiting associated with chemotherapy or radiotherapy and prevention of post-surgical nausea. Common off-label uses of Zofran are pediatric gastroenteritis (stomach flu), rheumatoid arthritis, schizophrenia, and opioid withdrawal. Zofran (generic: ondansetron) is an anti-nausea drug sold by GlaxoSmithKline (GSK).

In case you liked this informative article along with you would want to acquire guidance about riserpdal side effects kindly pay a visit to our web-page.
0 комментариев RSS
Нет комментариев
Автор топика запретил добавлять комментарии